Prevalence of a hobnail pattern in papillary, poorly differentiated, and anaplastic thyroid carcinoma: A possible manifestation of high-grade transformation

American Journal of Surgical Pathology

Volumn 39, Issue 2, 2015, Pages 260-265

  Amacher, Anne Marie ^a   Goyal, Bella ^a   Lewis, James S ^a   El Mofty, Samir K ^a   Chernock, Rebecca D ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

hobnail anaplastic thyroid carcinoma; micropapillary; papillary thyroid carcinoma; poorly differentiated thyroid carcinoma

Indexed keywords

B RAF KINASE; BRAF PROTEIN, HUMAN;

ADULT; AGED; CARCINOMA; CELL TRANSFORMATION; FEMALE; GENETICS; HUMAN; MALE; MIDDLE AGED; NUCLEOTIDE SEQUENCE; PATHOLOGY; PREVALENCE; RETROSPECTIVE STUDY; THYROID CARCINOMA, ANAPLASTIC; THYROID NEOPLASMS; YOUNG ADULT;

ADULT; AGED; CARCINOMA; CELL TRANSFORMATION, NEOPLASTIC; DNA MUTATIONAL ANALYSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; PREVALENCE; PROTO-ONCOGENE PROTEINS B-RAF; RETROSPECTIVE STUDIES; THYROID CARCINOMA, ANAPLASTIC; THYROID NEOPLASMS; YOUNG ADULT;

EID: 84922008829     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0000000000000329     Document Type: Review

References (32)

1. Regalbuto C, Malandrino P, Tumminia A, et al. A diffuse sclerosing variant of papillary thyroid carcinoma: clinical and pathologic features and outcomes of 34 consecutive cases. Thyroid. 2011;21:383-389.
2. Silver CE, Owen RP, Rodrigo JP, et al. Aggressive variants of papillary thyroid carcinoma. Head Neck. 2011;33:1052-1059.
3. Asioli S, Erickson LA, Righi A, et al. Papillary thyroid carcinoma with hobnail features: histopathologic criteria to predict aggressive behavior. Hum Pathol. 2013;44:320-328.
4. Lino-Silva L, Domnguez-Malago n HR, Caro-Sa nchez CH, et al. Thyroid gland papillary carcinomas with "micropapillary pattern," a recently recognized poor prognostic finding: clinicopathologic and survival analysis of 7 cases. Hum Pathol. 2012;43:1596-1600.
5. Chung Y, Lee JS, Park SY, et al. Histomorphological factors in the risk prediction of lymph node metastasis in papillary thyroid carcinoma. Histopathology. 2013;62:578-588.
6. Asioli S, Erickson LA, Sebo TJ, et al. Papillary thyroid carcinoma with prominent hobnail features: a new aggressive variant of moderately differentiated papillary carcinoma. A clinicopathologic, immunohistochemical, and molecular study of eight cases. Am J Surg Pathol. 2010;34:44-52.
7. Bai Y, Kakudo K, Li Y, et al. Subclassification of non-solid-type papillary thyroid carcinoma identification of high-risk group in common type. Cancer Sci. 2008;99:1908-1915.
8. Motosugi U, Murata S, Nagata K, et al. Thyroid papillary carcinoma with micropapillary and hobnail growth pattern: a histological variant with intermediate malignancy Thyroid. 2009;19:535-537.
9. Amin M, Ro JY, El-Sharkawy T, et al. Micropapillary variant of transitional cell carcinoma of the urinary bladder. Histologic pattern resembling ovarian papillary serous carcinoma. Am J Surg Pathol. 1994;18:1224-1232.
10. Bai Y, Kakudo K, Nakamura M, et al. Loss of cellular polarity/cohesiveness in the invasive front of papillary thyroid carcinoma and periostin expression. Cancer Lett. 2009;281:188-195.
11. Nassar H. Carcinomas with micropapillary morphology: clinical significance and current concepts. Adv Anat Pathol. 2004;11:297-303.
12. Amin M, Tamboli P, Merchant SH, et al. Micropapillary component in lung adenocarcinoma: a distinctive histologic feature with possible prognostic significance. Am J Surg Pathol. 2002;26:358-364.
13. Nagao T, Gaffey TA, Visscher DW, et al. Invasive micropapillary salivary duct carcinoma: a distinct histologic variant with biologic signficance. Am J Surg Pathol. 2004;28:319-326.
14. Walsh M, Bleiweiss IJ. Invasive micropapillary carcinoma of the breast: eighty cases of an underrecognized entity. Hum Pathol. 2001; 32:583-590.
15. Edge S, Byrd DR, Compton CC. AJCC Cancer Staging Manual. New York: Springer; 2010.
16. DeLellis RA, Lloyd RV, Heitz PU, et al. World Health Organization Classification of Tumours: Pathology and Genetics of Tumors of Endocrine Organs. Lyon: IARC Press; 2004.
17. Montemayor-Garcia C, Guo Z, Hardin H, et al. Paired related Homeobox 1 (PRRX1) is associated with epithelial-mesenchymal transition (EMT) in thyroid tumors. Mod Pathol. 2014;27(suppl 2): A632.
18. Buehler D, Hardin H, Shan W, et al. Expression of epithelialmesenchymal transition regulators SNAI2 and TWIST1 in thyroid carcinomas. Mod Pathol. 2013;26:54-61.
19. Hollier B, Evans K, Mani SA. The epithelial-to-mesenchymal transition and cancer stem cells: a coalition against cancer therapies. J Mammary Gland Biol Neoplasia. 2009;14:29-43.
20. Thiery J, Acloque H, Huang RY, et al. Epithelial-mesenchymal transitions in development and disease. Cell. 2009;139:871-890.
21. Polyak K, Weinberg RA. Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat Rev Cancer. 2009;9:265-273.
22. Wang H, Huang YW, Huang JS, et al. Anaplastic carcinoma of the thyroid arising more often from follicular carcinoma than papillary carcinoma. Ann Surg Oncol. 2007;14:3011-3018.
23. McIver B, Hay ID, Giuffrida DF, et al. Anaplastic thyroid carcinoma: a 50-year experience at a single institution. Surgery. 2001;130:1028-1034.
24. Venkatesh Y, Ordonez NG, Schultz PN, et al. Anaplastic carcinoma of the thyroid: a clincopathologic study of 121 cases. Cancer. 1990;66:321-330.
25. Carcangiu M, Steeper T, Zampi G, et al. Anaplastic thyroid carcinoma. A study of 70 cases. Am J Clin Pathol. 1985;83:135-158.
26. Quiros R, Ding HG, Gattuso P, et al. Evidence that one subset of anaplastic thyroid carcinomas are derived from papillary carcinomas due to BRAF and p53 mutations. Cancer. 2005;103:2261-2268.
27. Nikiforov Y. Genetic alterations involved in the transition from well-differentiated to poorly differentiated and anaplastic thyroid carcinomas. Endocr Pathol. 2004;15:319-327.
28. Wreesmann V, Ghossein RA, Patel SG, et al. Genome-wide appraisal of thyroid cancer progression. Am J Pathol. 2002;161: 1549-1556.
29. Rodrigues R, Roque L, Rosa-Santos J, et al. Chromosomal imbalances associated with anaplastic transformation of follicular thyroid carcinomas. Br J Cancer. 2004;90:492-496.
30. Costa AM, Herrero A, Fresnot MF, et al. BRAF mutation associated with other genetic events identifies a subset of aggressive papillary thyroid carcinoma. Clin Endocrinol. 2008;68:618-634.
31. Nikiforova MN, Kimura ET, Gandhi M, et al. BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas. J Clin Endocrinol Metab. 2003;88:5399-5404.
32. Rivera M, Ghossein RA, Schoder H. Histopathologic characterization of radioactive iodine refractory fluorodeoxyglucose-positron emission tomography-positive thyroid carcinoma. Cancer. 2008;113:48-56.